Fintel reports that on October 10, 2023, Ladenburg Thalmann initiated coverage of Zura Bio Ltd - (NASDAQ:ZURA) with a Buy recommendation.
Analyst Price Forecast Suggests 174.56% Upside
As of October 5, 2023, the average one-year price target for Zura Bio Ltd - is 18.62. The forecasts range from a low of 14.14 to a high of $23.10. The average price target represents an increase of 174.56% from its latest reported closing price of 6.78.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Zura Bio Ltd - is 0MM. The projected annual non-GAAP EPS is -0.96.
What is the Fund Sentiment?
There are 92 funds or institutions reporting positions in Zura Bio Ltd -. This is an increase of 83 owner(s) or 922.22% in the last quarter. Average portfolio weight of all funds dedicated to ZURA is 0.11%, an increase of 23,252.48%. Total shares owned by institutions increased in the last three months by 50,203.95% to 12,949K shares.
What are Other Shareholders Doing?
Great Point Partners holds 3,295K shares representing 7.56% ownership of the company.
Suvretta Capital Management holds 2,850K shares representing 6.54% ownership of the company.
Deep Track Capital holds 2,523K shares representing 5.79% ownership of the company.
Armistice Capital holds 950K shares representing 2.18% ownership of the company.
Citadel Advisors holds 713K shares representing 1.64% ownership of the company.
Zura Bio Background Information
(This description is provided by the company.)
JATT Acquisition Corp is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. While the Company may pursue its initial business combination with any business or industry, it intends to focus its search primarily in the life sciences sector.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
